| Literature DB >> 26395556 |
Sophie Nambot1,2, Alice Masurel1, Salima El Chehadeh1, Anne-Laure Mosca-Boidron2, Christel Thauvin-Robinet1,3, Mathilde Lefebvre1, Nathalie Marle2, Julien Thevenon1,2, Stéphanie Perez-Martin4, Véronique Dulieu5, Frédéric Huet4, Ghislaine Plessis6, Joris Andrieux7, Pierre-Simon Jouk8,9, Gipsy Billy-Lopez8, Charles Coutton10, Fanny Morice-Picard11, Marie-Ange Delrue11, Delphine Heron12, Caroline Rooryck13, Alice Goldenberg14, Pascale Saugier-Veber14, Géraldine Joly-Hélas15, Patricia Calenda16, Paul Kuentz3, Sylvie Manouvrier-Hanu17,18, Sophie Dupuis-Girod19, Patrick Callier2,3, Laurence Faivre1,3.
Abstract
The increasing use of array-CGH in malformation syndromes with intellectual disability could lead to the description of new contiguous gene syndrome by the analysis of the gene content of the microdeletion and reverse phenotyping. Thanks to a national and international call for collaboration by Achropuce and Decipher, we recruited four patients carrying de novo overlapping deletions of chromosome 9q33.3q34.11, including the STXBP1, the LMX1B and the ENG genes. We restrained the selection to these three genes because the effects of their haploinsufficency are well described in the literature and easily recognizable clinically. All deletions were detected by array-CGH and confirmed by FISH. The patients display common clinical features, including intellectual disability with epilepsy, owing to the presence of STXBP1 within the deletion, nail dysplasia and bone malformations, in particular patellar abnormalities attributed to LMX1B deletion, epistaxis and cutaneous-mucous telangiectasias explained by ENG haploinsufficiency and common facial dysmorphism. This systematic analysis of the genes comprised in the deletion allowed us to identify genes whose haploinsufficiency is expected to lead to disease manifestations and complications that require personalized follow-up, in particular for renal, eye, ear, vascular and neurological manifestations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26395556 PMCID: PMC4867444 DOI: 10.1038/ejhg.2015.202
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246